Search research articles

Related Concept Videos

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the exudate's...

Phases of Wound Repair

Phases of Wound Repair

Following injury, the integrity of the injured tissues must be reestablished. For example, in skin tissue, wound repair involves coordination among resident skin cells, blood mononuclear cells, extracellular matrix, growth factors, and cytokines to complete the healing cascade.
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Adipose-Derived Tissue in the Treatment of Dermal Fibrosis: Antifibrotic Effects of Adipose-Derived Stem Cells.

Annals of plastic surgery·2018

Same author

Deconstructing the stalled wound.

Wounds : a compendium of clinical research and practice·2015

Same author

Lipotransfer: the potential from bench to bedside: reply.

Annals of plastic surgery·2015

Same author

Lipotransfer: the potential from bench to bedside.

Annals of plastic surgery·2014

Same author

Bioengineered skin substitute considerations in the diabetic foot ulcer.

Annals of plastic surgery·2013

Same author

Scar management practice and science: a comprehensive approach to controlling scar tissue and avoiding hypertrophic scarring.

Advances in skin & wound care·2011

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 2, 2026

Development of a Benchtop Model for Evaluating the Compatibility of Wound Dressing Materials with Negative Pressure Wound Therapy Systems

Development of a Benchtop Model for Evaluating the Compatibility of Wound Dressing Materials with Negative Pressure Wound Therapy Systems

Published on: May 2, 2025

Chronic wound fluid--thinking outside the box.

Alan David Widgerow¹

¹Plastic Surgery Department, University of Witwatersrand, Johannesburg, South Africa. awidgerow@adarscience.com

Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society

|April 27, 2011

Summary

This summary is machine-generated.

Chronic wounds show high levels of matrix metalloproteinases (MMPs), especially MMP-9, in wound fluid, hindering healing. Targeting these MMPs and bacteria offers a dual defense strategy for chronic wound treatment.

More Related Videos

Collecting And Measuring Wound Exudate Biochemical Mediators In Surgical Wounds

Collecting And Measuring Wound Exudate Biochemical Mediators In Surgical Wounds

Published on: October 20, 2012

Related Experiment Videos

Last Updated: Jun 2, 2026

Development of a Benchtop Model for Evaluating the Compatibility of Wound Dressing Materials with Negative Pressure Wound Therapy Systems

Development of a Benchtop Model for Evaluating the Compatibility of Wound Dressing Materials with Negative Pressure Wound Therapy Systems

Published on: May 2, 2025

Collecting And Measuring Wound Exudate Biochemical Mediators In Surgical Wounds

Collecting And Measuring Wound Exudate Biochemical Mediators In Surgical Wounds

Published on: October 20, 2012

Area of Science:

Biomedical Science
Wound Healing Research
Extracellular Matrix Biology

Background:

Chronic wounds exhibit an imbalanced extracellular matrix (ECM) homeostasis, marked by increased ECM degradation and reduced synthesis.
Wound fluid traditionally reflects the wound's internal environment, indicating chronic status or treatment efficacy.
Elevated levels of matrix metalloproteinases (MMPs), particularly MMP-9, and high bacterial loads are characteristic of chronic wound fluid.

Purpose of the Study:

To investigate the role of wound fluid components, specifically MMPs, in the pathophysiology of chronic wounds.
To explore therapeutic strategies that target destructive elements in chronic wound fluid.
To evaluate agents with dual efficacy against MMP-9 and bacterial infections for chronic wound management.

Main Methods:

Analysis of chronic wound fluid composition, focusing on MMP levels and their correlation with wound status.
Identification of corrosive components in wound exudate contributing to ECM breakdown.
Assessment of agents with combined MMP-9 inhibitory and antibacterial properties.

Main Results:

Matrix metalloproteinases (MMPs), especially MMP-9, are found at higher concentrations in chronic wound fluid, contributing to ECM degradation.
A correlation exists between high bacterial levels and elevated MMP-9 in chronic wounds.
Agents with both MMP-9 inhibitory and antibacterial activity show potential for dual defense in chronic wound treatment.

Conclusions:

Targeting destructive elements in chronic wound fluid, such as MMP-9, can help restore homeostasis and promote healing.
Agents possessing both MMP-9 inhibitory and antibacterial properties offer a promising therapeutic approach for chronic wounds.
Modulating wound fluid composition presents a novel paradigm to initiate healing by addressing the destructive inflammatory cycle.